Destaques
Miocardite após 3ª dose de vacina da Pfizer em recrutas militares em Israel.
22 Mar, 2022 | 11:49hMyocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel – JAMA
Conteúdos relacionados:
Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Revisão | O desafio dos dogmas de tratamento sobre os quais as evidências são não existentes, fracas ou antigas.
22 Mar, 2022 | 11:48hChallenging management dogma where evidence is non-existent, weak or outdated – Intensive Care Medicine (se o acesso a este link for pago, tente este)
Estudo randomizado | Eficácia e aceitação de terapias dietéticas na síndrome do intestino irritável sem constipação: um estudo randomizado comparando aconselhamento dietético tradicional, dietas de baixo FODMAP e dietas sem glúten.
22 Mar, 2022 | 11:46hComentário: Traditional Dietary Advice Optimal as an Irritable Bowel Syndrome Therapy – HCPLivre
Conteúdos relacionados:
10 mistakes in dietary management of irritable bowel syndrome and how to avoid them.
Supplement: Irritable bowel syndrome and related conditions.
RCT: FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome.
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Guidelines for the treatment of irritable bowel syndrome
ACG Clinical Guideline: Management of irritable bowel syndrome
M-A: Efficacy of a low-FODMAP diet in adult irritable bowel syndrome
Diretriz | Manejo de anticoagulantes e antiplaquetários durante sangramento gastrintestinal agudo e período periendoscópico.
21 Mar, 2022 | 16:38h
Comentário no Twitter
BREAKING 🔥
Antiplatelets, anticoagulants and #EndoscopyNew CPG & dissemination tool.
An @AmCollegeGastro @CanGastroAssn co-production @AmJGastro and #JCAG@GriLeont @BryanGSauer @NeenaSAbrahamMD @alan_barkun @ThrombosisCan @LorenLaine2 #JenTelfordhttps://t.co/Ijs4jgOkPC pic.twitter.com/uUfN2zj3RS
— Journal of the Canadian Assn of Gastroenterology (@JCanAssnGastro) March 17, 2022
Estudo sobre lesão cerebral traumática destaca desigualdade global quanto às causas e tratamento.
21 Mar, 2022 | 16:36hComunicado de imprensa: Largest ever study on traumatic brain injury highlights global inequality in causes and treatment – University of Cambridge
Mais dados sugerem que há riscos reduzidos de internação e morte causadas pela variante Ômicron do SARS-CoV-2 em comparação à variante Delta.
21 Mar, 2022 | 16:34hComentário convidado: Omicron: fewer adverse outcomes come with new dangers – The Lancet
Comentário no Twitter
NEW—People with SARS-CoV-2 #omicron variant less likely to be admitted to hospital or die compared to those with delta variant, indicates large English study. https://t.co/xZvH5qMRDJ pic.twitter.com/fnn7xMBYDB
— The Lancet (@TheLancet) March 17, 2022
M-A | Posição prona para pacientes não entubados com insuficiência respiratória hipoxêmica aguda relacionada à COVID-19.
21 Mar, 2022 | 16:33hComentário convidado: The pandemic and the great awakening in the management of acute hypoxaemic respiratory failure – The Lancet Respiratory Medicine
Conteúdos relacionados:
RCT: Awake prone positioning reduces the need for intubation in patients with COVID-19.
Estudo mostra que não há risco aumentado de eventos neurológicos raros após vacinação contra Covid.
21 Mar, 2022 | 16:31hComunicado de imprensa: Study finds no increased risk of rare neurological events after covid vaccination – BMJ Newsroom
Editorial: The neurological safety of covid-19 vaccines
Uso da redução no risco absoluto para orientar a distribuição equitativa das vacinas contra COVID-19.
21 Mar, 2022 | 16:30hComunicado de imprensa: Researchers find equitable COVID-19 vaccine distribution can target risks in different geographical areas – University of New Mexico
Comentário no Twitter
Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines – Analysis by Fassler et al.
What's the role of NNV?#OpenAccess
▶️ https://t.co/Bb3HlJDRXz pic.twitter.com/MPxrGNHxum
— BMJ Evidence-Based Medicine (@BMJ_EBM) March 17, 2022
Estudo randomizado | Suplementação de flavonóis de cacau mostrou-se promissora na prevenção de eventos cardiovasculares.
21 Mar, 2022 | 16:29h
Comentário no Twitter (fio – clique para saber mais)
In @AJCNutrition: @HowardSesso, Dr. JoAnn Manson of @BWHDPM @BrighamWomens & colleagues report the main findings of the first ever randomized trial of a cocoa flavanol supplement on cardiovascular disease endpointshttps://t.co/0F5v8WqzdM and https://t.co/vA3wwT0Amw (1 of 5) pic.twitter.com/X08hiNUCzK
— BrighamResearch (@BrighamResearch) March 16, 2022